Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × nintedanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 16 Ovarian Neoplasms 6 Neoplasms 6 Colorectal Neoplasms 4 Recurrence 3 Prostatic Neoplasms 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Radiation Pneumonitis 2 Peritoneal Neoplasms 2 Mesothelioma, Malignant 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Glioblastoma 2 Fallopian Tube Neoplasms 2 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rectal Neoplasms 1 Patients With Any Advanced Solid Tumors 1 Ovarian Diseases 1 Oligodendroglioma 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Mesothelioma 1 Melanoma, Cutaneous Malignant 1 Malignant Solid Tumour 1

Interventions

Doxorubicin 120 Ifosfamide 70 Radiotherapy 65 Cyclophosphamide 61 Gemcitabine 53 Filgrastim 46 Trabectedin 36 pazopanib 34 Docetaxel 34 Etoposide 33 pembrolizumab 32 Vincristine 30 Cisplatin 29 Nivolumab 27 Irinotecan 21 Magnetic Resonance Spectroscopy 20 Carboplatin 20 Ipilimumab 19 Surgical Procedures, Operative 18 Radiation 18 Temozolomide 17 Mesna 16 Melphalan 16 Biopsy 16 Bevacizumab 16 Sirolimus 15 Granulocyte Colony-Stimulating Factor 15 Drug Therapy 15 Dactinomycin 15 Blood Specimen Collection 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02808247 2021-09-20

ANITA

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡